EXPLEOSOL Expleo Solutions Q4 FY25 results (Jan–Mar 2025) and concall
Expleo Solutions reported a strong FY25 with 6.2% revenue growth and an 80 bps EBITDA margin expansion, driven by strategic focus on existing clients, US, and Middle East expansion, and significant AI investments. While Q4 saw a slight QoQ revenue dip and margin compression due to wage hikes, the company remains optimistic about FY26, expecting continued growth from BFSI, retail, defense, and AI-driven services, despite ongoing slowdowns in auto and aero sectors.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 259 | 258 | 256 |
| EBITDA | 42 | 39 | 40 |
| Net profit | 35 | 20 | 24 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
